SNY, BMY, REGN and others ramp up 2025 dealmaking as pharma/biotech giants chase innovation across key growth areas.

Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. have announced a strategic research collaboration within the field of conditionally activated bispecific therapeutics for the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Regeneron – which acquired DB-OTO as part of its $109 million acquisition of Decibel Therapeutics in 2023 – is one of a handful of biopharma companies working on gene therapies for this type ...

Merger & Acquisition News Market Data Key Market Data Earnings Calendar Currencies Cryptocurrency Prices Sectors ... REGN Regeneron Pharmaceuticals, Inc. Stock Price & Overview Follow $523.53 5.93 ...